Filecoin Price Rebounds 27% as Data Narrative Builds

U.S. stocks had a mixed week, with crypto-linked equities rallying despite legislative setbacks, while Bank of America warned of weaker investment banking outlook. Generac surged on a $2.4B Amazon deal, Tempus AI rose post-conference, and J.B. Hunt fell after an earnings warning. Bitcoin gained 5.5%.

XRP rose 6% in 24 hours, reaching $1.40, as whale inflows to Binance hit a 6-month high of 1.6 billion XRP. The surge follows a selloff after the Clarity Act's failure. Evernorth raised $30 million for spot XRP investments, pending a SPAC merger and Nasdaq listing under XRPN.

Enphase Energy (ENPH) fell 5% to $34.29, while First Solar (FSLR) and Sunrun (RUN) each dropped 4%, driven by broader solar sector weakness. The decline follows a Fed rate hike, which impacts residential solar demand due to financing costs. The Invesco Solar ETF (TAN) also fell 2%, while the S&P 500 ETF (SPY) declined 0.2%.

Xenon Pharmaceuticals (XENE) halted enrollment in a depression study due to adverse events, causing its stock to drop 29% to $40.60. The company submitted a new drug application for its epilepsy treatment, azetukalner, which showed promising results in reducing seizures. Analysts cut price targets but remain optimistic about the epilepsy drug's potential.

XORTX Therapeutics (XRTX) shares rose 12% after announcing plans to submit an Investigational New Drug application to the FDA in Q4 2026. The stock traded at $1.8997, up from $1.99, with a 52-week range of $1.59 to $7.05.

Strategy Inc. shares rose 13.66% to $150.32 as Bitcoin rallied and Wall Street analysts raised price targets. The company holds 845,050 Bitcoin, worth about $66 billion. Strategy also repurchased $139.3 million in shares. Analysts see significant upside, with an average price target of $228.53. The stock is highly volatile, moving in tandem with Bitcoin.